Home.
BrilliantStrings is a mechanotherapeutics company with a focus on Complete Human Collagen(CHC™)
About Us
BrilliantStrings Therapeutics has transformed decades of paradigm-shifting academic research in extracellular matrix mechanochemistry and deep expertise in controlling collagen assembly into a unique, healing biomaterial. Our Complete Human Collagen (CHC™) mechano-therapeutic, is capable of rapidly repairing injured or degenerated connective tissue and constitutes “a first-in-class” achievement. The CHC™ delivery platform addresses a very large unmet need for a wide range of Ortho-Musculoskeletal conditions. Our first target market is the Rotator Cuff.
A next generation approach to healing
In comparison to currently available ‘first generation’ therapeutics that are weakly effective, BrilliantStrings has a ‘next generation’ solution: a complete human collagen biomaterial AND platform that makes a quantum leap forward in the effort to produce complete and rapid healing. The company has systematically developed unique know-how to manufacture human collagen at commercial scale as well as the approach to precisely target and deliver a highly-efficient injectable collagen dose directly to the injury site. Together, these technical advances promise to usher in a new paradigm for orthopedic musculoskeletal injury treatment and wound healing.
Stable Complete Collagen Packaged for Delivery
Proprietary liquid-crystal packaging protects complete collagen and controllably delivers it to injury. Patent Filed.Company.
Company Background
BrilliantStrings Therapeutics (BSTHX) is a healing biomaterials platform company that provides rapid repair and improved recovery of injured or age-degenerated human connective tissues found throughout the body (as depicted in the image). Our unique approach to healing transcends current ‘first generation’ collagen therapies and ushers in a new paradigm of active healing in orthopedics. We are the first company to provide a complete human collagen-based healing solution not only for clinically significant tissue tears that require surgical intervention, but also for the millions of people who do not yet qualify for surgery and suffer untreated and in chronic pain.Injectable Therapeutic
To address the majority of patients pursing orthopedic treatment for rotator cuff and other tendon injuries, but presenting an injury that does not require surgical repair, we are developing an injection of complete human collagen. The first of it's kind the BST collagen patch contains a dense collections of particals and a controlled release. The collagen will home to the injury and will particpate in the tendon repair. With the aid of live ultrasound imaging the clinician can locate the injury and deliver the collagen solution within the immediate proximity of the damaged tissue.Science.
Our science tells us that delivering Complete Collagen will improve outcomes!
Scientific Breakthrough
Collagen molecules “home” to injury and with the proper application of force, will promote the healing process.
Team.
Jeff Ruberti, Ph.D.
CEO
Professor of Bioengineering
Northeastern University
Fellow AIMBE 2022
Martha Shadan, MBA
Board Chairwoman
Former CEO Rotation Medical
Former CEO Miach Orthopaedics
AdvaMed Board Member
Luke Oh, M.D.
Consultant Surgeon
Medical Director of Orthopaedic Sports Medicine, Rothman Orthopaedics FL & AdventHealth
Head Team Surgeon, Orlando Magic (NBA)
Scott Weiss, MBA
Chief Operations
Business Founder
Jackson Oakmont LLC
Author
News.
BST is Named as an Awardee in Johnson & Johnson Innovation and The Johnson & Johnson Family of Companies in Japan Inaugural Smart Healthy Aging QuickFire Challenge
FOR IMMEDIATE RELEASE
Cambridge, MA - BrilliantStrings Therapeutics is developing transformative, direct protein therapies to accelerate the healing of soft connective tissues, is pleased to announce that we are one of 4 companies to be selected as an awardee in the Johnson & Johnson Innovation and The Johnson & Johnson Family of Companies in Japan Inaugural Smart Healthy Aging QuickFire Challenge. "This inaugural QuickFire challenge was designed to identify companies and technologies to aid in Japan's aging population. We are thrilled that the team at Johnson & Johnson Innovation and The Johnson & Johnson Family of Companies in Japan recognized the healing properties of CHC™ and the promise it brings to the elderly patient population" said Dr. Jeffrey Ruberti, CEO of BrilliantStrings. "Our injectable CHC™ product is focused on healing tissue damage too small for surgical repair."
Related Links:
Johnson & Johnson Innovation
Twitter
Contact.
BrilliantStrings Therapeutics, Inc.
700 Main Street, North Cambridge, MA 02139
Learn more about our technology.